Seeking Alpha

NPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of...

NPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of its experimental short bowel syndrome therapy - Gattex - including two patients dying from cancer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)